BDBM465809 Preparation of (S)-4-(3-(5-acryloyl-5-azaspiro[2.4]heptan-6-yl)-8-aminoimidazo[1,5-a]pyrazin-1-yl)-N-(4-(trifluoromethyl)pyridin-2-yl)benzamide::US10793576, Example 41

SMILES Nc1nccn2c(nc(-c3ccc(cc3)C(=O)Nc3cc(ccn3)C(F)(F)F)c12)C1CC2(CC2)CN1C(=O)C=C

InChI Key InChIKey=BFIHVNMVZKSOFA-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 465809   

TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465809(Preparation of (S)-4-(3-(5-acryloyl-5-azaspiro[2.4...)
Affinity DataIC50:  52nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent